March 16 to May 16, 2026
The Pediatric Research Foundation aims to support early-career researchers (with less than 10 years of experience) by providing significant funding for innovative clinical or basic research projects aimed at improving the health of children and adolescents.
For four years now, the Foundation has been supporting the next generation of scientists through its National Competition. To date, $320,000 has been awarded to 13 talented young researchers, enabling them to launch their pilot projects and advance pediatric research in Quebec.
For this 4th edition, The Foundation is proud to announce the launch of three prestigious grants:
- Power Corporation of Canada Innovation Grant – $60,000
- BMO Excellence Grant – $45,000
- Pediatric Research Foundation Grant – $45,000
These grants aim to support researchers in developing innovative pilot projects, offering them a unique opportunity to stand out and strengthen their applications to major funding agencies.
With this support, the Foundation reaffirms its commitment to excellence and innovation in pediatric research, while contributing to the advancement of knowledge and the improvement of care for children.
Thank you to our donors for supporting the next generation of pediatric researchers by offering an Innovation Grant and an Excellence Grant.
The PRF aims to:
- Provide significant support for the implementation of pilot projects that will subsequently lead to major grants.
- Encourage collaborative research between centres.
- Promote the decompartmentalization of disciplines within pediatric research.
- Promote excellence, innovation and active participation in scientific outreach activities.
- Support vulnerable populations to reduce inequalities in child health (e.g., children from disadvantagedbackgrounds, children with disabilities, or children from Indigenous communities).
Eligibility rules
Principal investigator eligibility
- Researcher supported by a pediatric research center recognized by the FRQ-S or by another peripheral centre, a university that conducts research involving children and adolescents.
- 10 years or less of experience as an independent researcher.
- The researcher must agree to participate in the PRF’s promotional activities for their project.
- Annual reporting for 5 years based on PRF form.
- Early career researchers without major funding will be given preference for external peer review.
- Commitment to knowledge transfer and advancement.
- Integrates a DEI culture (diversity, equity, inclusion).
Co-investigators
- Can be senior researchers.
- One of the researchers/collaborators must be attached to another university and come from a research center in Quebec other than that of the principal investigator.
- Two of the researchers/collaborators must come from a research center in Quebec other than that of the principal investigator, and at least one of them must be attached to another university.
The project (evaluation criteria)
- 2-year period.
- Funding amount = $60,000 ($30,000 X 2 years) or $45,000 ($22,500 x 2 years).
- Original (new project).
- Structuring (leverage effect of the proposed project).
- Innovative (must be in innovative fields).
- Has impact on children’s health.
- Clear plan for knowledge transfer.
- Must not be funded by an organization outside the research center.
- Has the potential to lead to wider research program.
- Quality of the popularized summary: ability to explain and promote the project for a non-scientific audience or for a donor.
The Innovation Grant will be awarded to a project that meets these criteria and the following:
- Presenting high scientific quality.
- Based on an original idea or a disruptive innovation.
- Having the potential to transform knowledge and stimulate new approaches in pediatric health.
- Allowing the generation of preliminary results establishing proof of concept;
- Having a catalytic effect, promoting access to other sources of financing or the expansion of the project.
Application
- Complete a standardized application form for the competition via the PRF website.
- Obtain a letter of support from the center director or an academic institution.
- Include Curriculum Vitae of the FRQ-S principal investigator with the usual appendices.
The competition is open to all areas of pediatric health sciences, including medicine, social sciences, psychology, education, nursing, nutrition, public health, etc., and all other related disciplines.
Timeline
- Competition – March 16 to May 16, 2026.
- Deadline for electronic submission of the application – May 16, 2026, at 11:59 p.m.
- Announcement of winners – June 2026 (date to be confirmed).
- Presentation of scholarships – with donors – 2026 Quebec Congress on Mother-Child Research – (date to be confirmed).
Evaluation committee
- Dr. Bruno Piedboeuf, President of the PRF Scientific Committee and Director, Reproduction, Maternal and Child Health Research Axis, CHU de Québec
- The committee is composed of reviewers from each of the following 4 research centres: CHU de Québec, CHU de Sherbrooke, CHU Sainte-Justine and McGill University Centre.
Contact:
- For questions about the contest, eligibility rules and for receipt of forms before May 16, 2026 -11:59pm. Contact Sylviane Chatel at schatel@fondationrecherchepediatrique.ca at (514) 882-0700 or Carole Lalande at clalande@fondationrecherchepediatrique.ca at (514) 595-5730 ext. 222.
Application form for young researchers 2026
"*" indicates required fields
2025 Awards winners
- Power Corporation of Canada INNOVATION Grant
Dr. Alexander Weil, CHU Sainte- Justine and Prof. Sara Larivière, CIUSSS de l’Estrie – CHUS, for their project “Towards precision surgery for focal and generalized epilepsy through network mapping“.
- BMO EXCELLENCE Grant
Dr. Andréanne Villeneuve, CHU Sainte- Justine, for her project “Optimizing adherence to transfusion thresholds in premature infants: Study of decision-making processes in red blood cell and platelet transfusion practices in neonatology”. - Pediatric Research Foundation Grant
Dr. Marc Beltempo, Montreal Children’s Hospital – McGill, for his project “Redefining necrotizing enterocolitis in neonates using unsupervised machine learning”. - Pediatric Research Foundation Grant
Dr. Angeliki Makri, Montreal Children’s Hospital – McGill, for her project “OPEN-D: Onboarding Platform for the Education of New patients with Diabetes. A Personalized Chatbot for Children with Type 1 Diabetes (T1D) and Their Families”.

2024 Awards winners
- Pediatric Research Foundation INNOVATION grant
Prof. Gabriel Bossé, CHU de Laval – Centre mère-enfant, for his project “Understanding neonatal opioid exposure long-term consequences”.
- Pediatric Research Foundation Grant
Dr. Wissam Shalish, Montreal Children’s Hospital – McGill, for his project “Intermittent hypoxias and associated modifiable risk factors during neonatal hospitalization in very preterm infants”. - Pediatric Research Foundation Grant
Dr. Ugochinyere Vivian, Montreal Children’s Hospital- McGill, for her project “Examining severe maternal morbidity and socioeconomic disparity as determinants of childhood neurodevelopmental disorders”. - Pediatric Research Foundation Grant
Dr. Emilie Beaulieu, CHU de Laval Centre mère-enfant, for her project “Rethink injury prevention recommendations to reduce anxiety and promote the child’s overall well-being“.
2023 Awards winners
- POWER CORPORATION CANADA Grant
Dr. Raoul Santiago, CHU de Laval – Centre mère-enfant Soleil, for his project “Provincial prospective registry on the use of exception drugs in pediatric oncology.” - Pediatric Research Foundation Grant
Dr. Kenneth Myers, Montreal Children’s Hospital, for his project “Premature telomere shortening: a treatable disease mechanism in mitochondrial DNA depletion disorders?” - Pediatric Research Foundation Grant
Dr. Alexandre Reynaud, Montreal General Hospital, for his project “Evaluation of the efficacy of a new binocular treatment for amblyopia by diacopic reading of electronic books.” - Pediatric Research Foundation Grant
Dr. Mallory Downie, Montreal Children’s Hospital, for her project “Using genetics to understand phenotypic variability in childhood nephrotic syndrome for precision medicine.”